Myeloid-derived suppressor cells (MDSCs) are major negative regulators of immune responses in cancer and chronic infections. It remains unclear if regulation of MDSC activity in different conditions is controlled by similar mechanisms. We compared MDSCs in mice with cancer and lymphocytic choriomeningitis virus (LCMV) infection. Chronic LCMV infection caused the development of monocytic MDSCs (M-MDSCs) but did not induce polymorphonuclear MDSCs (PMN-MDSCs). In contrast, both MDSC populations were present in cancer models. An acquisition of immune-suppressive activity by PMN-MDSCs in cancer was controlled by IRE1α and ATF6 pathways of the endoplasmic reticulum (ER) stress response. Abrogation of PMN-MDSC activity by blockade of the ER stress response resulted in an increase in tumor-specific immune response and reduced tumor progression. In contrast, the ER stress response was dispensable for suppressive activity of M-MDSCs in cancer and LCMV infection. Acquisition of immune-suppressive activity by M-MDSCs in spleens was mediated by IFN-γ signaling. However, it was dispensable for suppressive activity of M-MDSCs in tumor tissues. Suppressive activity of M-MDSCs in tumors was retained due to the effect of IL-6 present at high concentrations in the tumor site. These results demonstrate disease- and population-specific mechanisms of MDSC accumulation and the need for targeting different pathways to achieve inactivation of these cells.
Evgenii N. Tcyganov, Shino Hanabuchi, Ayumi Hashimoto, David Campbell, Gozde Kar, Timothy W.F. Slidel, Corinne Cayatte, Aimee Landry, Fernanda Pilataxi, Susana Hayes, Brian Dougherty, Kristin C. Hicks, Kathy Mulgrew, Chih-Hang Anthony Tang, Chih-Chi Andrew Hu, Wei Guo, Sergei Grivennikov, Mohammed-Alkhatim A. Ali, Jean-Christophe Beltra, E. John Wherry, Yulia Nefedova, Dmitry I. Gabrilovich
Title and authors | Publication | Year |
---|---|---|
Delineation of monocytic and early‐stage myeloid‐derived suppressor cells in the peripheral blood of patients with hepatocarcinoma
Chivite\u2010Lacaba M, Justo I, Utrero\u2010Rico A, Caso O, González\u2010Cuadrado C, Del Rey MJ, Laguna\u2010Goya R, Arroyo\u2010Ródenas J, Alfocea\u2010Molina Á, Ruigómez\u2010Martín CC, Serrano M, Pascual\u2010Palacios L, Mancebo ME, Paz\u2010Artal E |
International Journal of Cancer | 2025 |
MiR- 150 deletion promotes lung tumor growth by upregulating P-STAT3 and ROS in MDSCs
Qin A, Chen H, Xu F, Li W, Guo S, Zhang G, Zhang A, Zheng A, Tian F, Zheng Q |
Scientific Reports | 2025 |
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting
Eruslanov E, Nefedova Y, Gabrilovich DI |
Nature immunology | 2025 |
Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy.
He J, Zhou Y, Sun L |
Cell communication and signaling : CCS | 2024 |
Parasite-induced IFN-γ regulates host defense via CD115 and mTOR-dependent mechanism of tissue-resident macrophage death
Martin AT, Giri S, Safronova A, Eliseeva SI, Kwok SF, Yarovinsky F |
PLoS pathogens | 2024 |
Endoplasmic Reticulum Stress in Hypertension and Salt Sensitivity of Blood Pressure.
Balhara M, Neikirk K, Marshall A, Hinton A Jr, Kirabo A |
Current Hypertension Reports | 2024 |
Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives
Lin H, Liu C, Hu A, Zhang D, Yang H, Mao Y |
Journal of Hematology & Oncology | 2024 |
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma.
De Leo A, Ugolini A, Yu X, Scirocchi F, Scocozza D, Peixoto B, Pace A, D'Angelo L, Liu JKC, Etame AB, Rughetti A, Nuti M, Santoro A, Vogelbaum MA, Conejo-Garcia JR, Rodriguez PC, Veglia F |
Immunity | 2024 |
PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma
Liu X, Liu M, Wu H, Tang W, Yang W, Chan TT, Zhang L, Chen S, Xiong Z, Liang J, Wai-Yiu Si-Tou W, Shu T, Li J, Cao J, Zhong C, Sun H, Kwong TT, Leung HH, Wong J, Bo-San Lai P, To KF, Xiang T, Jao-Yiu Sung J, Chan SL, Zhou J, Sze-Lok Cheng A |
2024 | |
Glioma-derived M-CSF and IL-34 license M-MDSCs to suppress CD8+ T cells in a NOS-dependent manner
Takacs GP, Garcia JS, Hodges CA, Kreiger CJ, Sherman A, Harrison JK |
2024 | |
Divergent Processing of Cell Stress Signals as the Basis of Cancer Progression: Licensing NFκB on Chromatin
Vlahopoulos SA |
International Journal of Molecular Sciences | 2024 |
CSF1R Ligands Expressed by Murine Gliomas Promote M-MDSCs to Suppress CD8+ T Cells in a NOS-Dependent Manner
Takacs GP, Garcia JS, Hodges CA, Kreiger CJ, Sherman A, Harrison JK |
Cancers | 2024 |
Eliminating a barrier: Aiming at VISTA, reversing MDSC-mediated T cell suppression in the tumor microenvironment
Deng Y, Shi M, Yi L, Naveed Khan M, Xia Z, Li X |
Heliyon | 2024 |
Homeostasis control in health and disease by the unfolded protein response.
Acosta-Alvear D, Harnoss JM, Walter P, Ashkenazi A |
Nature reviews. Molecular cell biology | 2024 |
Immunologic Crosstalk of Endoplasmic Reticulum Stress Signaling in Bladder Cancer.
Wan S, Li KP, Wang CY, Yang JW, Chen SY, Wang HB, Li XR, Yang L |
Current cancer drug targets | 2024 |
Identification of a distinctive immunogenomic gene signature in stage-matched colorectal cancer
Ahluwalia P, Mondal AK, Vashisht A, Singh H, Alptekin A, Ballur K, Omar N, Ahluwalia M, Jones K, Barrett A, Kota V, Kolhe R |
Journal of Cancer Research and Clinical Oncology | 2024 |
Endoplasmic reticulum stress mediates the myeloid-derived immune suppression associated with cancer and infectious disease
Lou X, Gao D, Yang L, Wang Y, Hou Y |
Journal of Translational Medicine | 2023 |
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Hopkins FR, Govender M, Svanberg C, Nordgren J, Waller H, Nilsdotter-Augustinsson Å, Henningsson AJ, Hagbom M, Sjöwall J, Nyström S, Larsson M |
Frontiers in immunology | 2023 |
Glioma-derived CCL2 and CCL7 mediate migration of immune suppressive CCR2+/CX3CR1+ M-MDSCs into the tumor microenvironment in a redundant manner
Takacs GP, Kreiger CJ, Luo D, Tian G, Garcia JS, Deleyrolle LP, Mitchell DA, Harrison JK |
Frontiers in immunology | 2023 |
Genomic and clinical features of endoplasmic reticulum stress factor in digestive system pan-cancer studies
Yao S, Yu Y, Xu L, Pan X |
Frontiers in Oncology | 2023 |
Myeloid-Derived Suppressor Cells in Cancer and COVID-19 as Associated with Oxidative Stress
Andrés CM, Pérez de la Lastra JM, Juan CA, Plou FJ, Pérez-Lebeña E |
Human vaccines | 2023 |
Functional states of myeloid cells in cancer
van Vlerken-Ysla L, Tyurina YY, Kagan VE, Gabrilovich DI |
Cancer Cell | 2023 |
Therapeutic targeting of tumour myeloid cells.
Barry ST, Gabrilovich DI, Sansom OJ, Campbell AD, Morton JP |
Nature reviews. Cancer | 2023 |
Cancer immunity and immunotherapy beyond COVID-19
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP |
Cancer Immunology, Immunotherapy | 2023 |
The role of myeloid-derived suppressor cells in liver cancer
Zhou S, Zhao Z, Zhong H, Ren Z, Li Y, Wang H, Qiu Y |
Discover. Oncology | 2023 |
Control of immune cell function by the unfolded protein response.
Di Conza G, Ho PC, Cubillos-Ruiz JR, Huang SC |
Nature reviews. Immunology | 2023 |
How the Unfolded Protein Response Is a Boon for Tumors and a Bane for the Immune System
Raines LN, Huang SC |
ImmunoHorizons | 2023 |
Myeloid cells in the era of cancer immunotherapy: Top 3 unanswered questions.
Chaib M, Tanveer UA, Makowski L |
Pharmacology & Therapeutics | 2023 |
The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis.
Len JS, Koh CWT, Chan KR |
Viruses | 2023 |
Activating transcription factor 3 functionally reprograms the bone marrow niche to sustain breast cancer
Milena Perrone, Claudia Chiodoni, Mara Lecchi, Laura Botti, Matteo Milani, Daniele Lecis, Elda Tagliabue, Paolo Verderio, Sabina Sangaletti, Mario Colombo |
Cancer research | 2022 |
Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression
Sean Colligan, Robert A Zollo, Jennifer Peresie, Elliot D Kramer, Joseph Barbi, Prashant K Singh, Jianmin Wang, Mateusz Opyrchal, David Sykes, Michael Nemeth, Scott I. Abrams |
Journal of Clinical Investigation | 2022 |
Myeloid-Derived Suppressor Cells in Solid Tumors
T Ma, B Renz, M Ilmer, D Koch, Y Yang, J Werner, A Bazhin |
Cells | 2022 |
New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19
S Park, D Nam, H Seong, Y Hahn |
Frontiers in immunology | 2022 |
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases.
Faccani C, Rotta G, Clemente F, Fedeli M, Abbati D, Manfredi F, Potenza A, Anselmo A, Pedica F, Fiorentini G, Villa C, Protti MP, Doglioni C, Aldrighetti L, Bonini C, Casorati G, Dellabona P, de Lalla C |
Life science alliance | 2022 |
Dampened Inflammatory Signalling and Myeloid-Derived Suppressor-Like Cell Accumulation Reduces Circulating Monocytic HLA-DR Density and May Associate With Malignancy Risk in Long-Term Renal Transplant Recipients
Bottomley MJ, Harden PN, Wood KJ, Hester J, Issa F |
Frontiers in immunology | 2022 |
Immunotherapy of targeting MDSCs in tumor microenvironment
Sui H, Dongye S, Liu X, Xu X, Wang L, Jin CQ, Yao M, Gong Z, Jiang D, Zhang K, Liu Y, Liu H, Jiang G, Su Y |
Frontiers in immunology | 2022 |
Immunosuppression in tumor immune microenvironment and its optimization from CAR-T cell therapy
Liu Z, Zhou Z, Dang Q, Xu H, Lv J, Li H, Han X |
Theranostics | 2022 |
Chemotherapy-induced complement signaling modulates immunosuppression and metastatic relapse in breast cancer
Monteran L, Ershaid N, Doron H, Zait Y, Scharff Y, Ben-Yosef S, Avivi C, Barshack I, Sonnenblick A, Erez N |
Nature Communications | 2022 |
Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations
Martin C, Dhôte T, Ladjemi MZ, Andrieu M, Many S, Karunanithy V, Pène F, Da Silva J, Burgel PR, Witko-Sarsat V |
Frontiers in immunology | 2022 |
Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity.
Salvagno C, Mandula JK, Rodriguez PC, Cubillos-Ruiz JR |
Trends in Cancer | 2022 |
TLR7 controls myeloid-derived suppressor cells expansion and function in the lung of C57BL6 mice infected with Schistosoma japonicum.
Zhou L, Zhu Y, Mo L, Wang M, Lin J, Zhao Y, Feng Y, Xie A, Wei H, Qiu H, Huang J, Yang Q |
PLoS neglected tropical diseases | 2022 |
Endoplasmic Reticulum Quality Control in Immune Cells
Y Jiang, Z Tao, H Chen, S Xia |
Frontiers in Cell and Developmental Biology | 2021 |
IFN-γ mediates Paneth cell death via suppression of mTOR
A Araujo, A Safronova, E Burger, A López-Yglesias, S Giri, ET Camanzo, AT Martin, S Grivennikov, F Yarovinsky |
eLife | 2021 |
Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity
GD Conza, CH Tsai, H Gallart-Ayala, YR Yu, F Franco, L Zaffalon, X Xie, X Li, Z Xiao, LN Raines, M Falquet, A Jalil, JW Locasale, P Percipalle, D Masson, SC Huang, F Martinon, J Ivanisevic, PC Ho |
Nature Immunology | 2021 |